Symptomatic SARS-CoV-2 Reinfection in a Healthy Healthcare Worker in Italy Confirmed by Whole-Genome Sequencing.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
12 05 2021
Historique:
received: 19 04 2021
revised: 06 05 2021
accepted: 11 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 2 7 2021
Statut: epublish

Résumé

This study describes a case of SARS-CoV-2 reinfection confirmed by whole-genome sequencing in a healthy physician who had been working in a COVID-19 hospital in Italy since the beginning of the pandemic. Nasopharyngeal swabs were obtained from the patient at each presentation as part of routine surveillance. Nucleic acid amplification testing was performed on the two samples to confirm SARS-CoV-2 infection, and serological tests were used to detect SARS-CoV-2 IgG antibodies. Comparative genome analysis with whole-genome sequencing was performed on nasopharyngeal swabs collected during the two episodes of COVID-19. The first COVID-19 episode was in March 2020, and the second was in January 2021. Both SARS-CoV-2 infections presented with mild symptoms, and seroconversion for SARS-CoV-2 IgG was documented. Genomic analysis showed that the viral genome from the first infection belonged to the lineage B.1.1.74, while that from the second infection to the lineage B.1.177. Epidemiological, clinical, serological, and genomic analyses confirmed that the second episode of SARS-CoV-2 infection in the healthcare worker met the qualifications for "best evidence" for reinfection. Further studies are urgently needed to assess the frequency of such a worrisome occurrence, particularly in the light of the recent diffusion of SARS-CoV-2 variants of concern.

Identifiants

pubmed: 34066205
pii: v13050899
doi: 10.3390/v13050899
pmc: PMC8150928
pii:
doi:

Substances chimiques

Antibodies, Viral 0
Immunoglobulin G 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Clin Infect Dis. 2020 Nov 19;71(16):2027-2034
pubmed: 32221519
Lancet Infect Dis. 2021 Jan;21(1):52-58
pubmed: 33058797
Microbiol Resour Announc. 2021 Jan 28;10(4):
pubmed: 33509997
Infection. 2020 Dec;48(6):965-967
pubmed: 32415334
SN Compr Clin Med. 2020;2(6):710-713
pubmed: 32838134
Clin Infect Dis. 2021 Nov 2;73(9):e2985-e2991
pubmed: 33315049
Clin Infect Dis. 2021 Nov 2;73(9):e3002-e3008
pubmed: 33219681
Nature. 2020 Aug;584(7819):115-119
pubmed: 32454513
Clin Med (Lond). 2021 Jan;21(1):e52-e53
pubmed: 33303623
Lancet Infect Dis. 2020 May;20(5):565-574
pubmed: 32213337
J Infect. 2020 Aug;81(2):e72-e73
pubmed: 32389787
Nat Med. 2020 Aug;26(8):1200-1204
pubmed: 32555424
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
Nat Med. 2020 Nov;26(11):1691-1693
pubmed: 32929268
J Clin Microbiol. 2021 Mar 19;59(4):
pubmed: 33361342
J Infect. 2020 Nov;81(5):816-846
pubmed: 32619697
J Infect. 2020 May;80(5):e14-e17
pubmed: 32171867
Clin Infect Dis. 2021 Nov 2;73(9):e2823-e2825
pubmed: 32964927
Clin Infect Dis. 2021 Jul 15;73(2):354-356
pubmed: 32887979
Clin Infect Dis. 2021 Nov 16;73(10):1945-1946
pubmed: 33566076
Lancet Infect Dis. 2021 Jun;21(6):e142
pubmed: 33242475
N Engl J Med. 2021 Jan 7;384(1):80-82
pubmed: 33270381
Clin Infect Dis. 2021 Nov 2;73(9):e2946-e2951
pubmed: 32840608

Auteurs

Daniela Loconsole (D)

Department of Biomedical Sciences and Human Oncology-Hygiene Section, University of Bari, 70124 Bari, Italy.

Anna Sallustio (A)

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, 70124 Bari, Italy.

Marisa Accogli (M)

Department of Biomedical Sciences and Human Oncology-Hygiene Section, University of Bari, 70124 Bari, Italy.

Francesca Centrone (F)

Department of Biomedical Sciences and Human Oncology-Hygiene Section, University of Bari, 70124 Bari, Italy.

Daniele Casulli (D)

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, 70124 Bari, Italy.

Antonino Madaro (A)

Department of Prevention, Local Health Unit of Bari, 70124 Bari, Italy.

Ersilia Tedeschi (E)

Covid-Unit, Hospital F. Miulli, Acquaviva delle Fonti, 70124 Bari, Italy.

Antonio Parisi (A)

Istituto Zooprofilattico Sperimentale della Puglia e della Basilicata, 71121 Foggia, Italy.

Maria Chironna (M)

Department of Biomedical Sciences and Human Oncology-Hygiene Section, University of Bari, 70124 Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH